Physician profile
Kathryn Das
NPI 1750760542
$13,018.88
in general payments reported to CMS, 2019-2025
34 companies · $2,482 in 2025
The $2,482 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $2,739 · 2021: $1,570 · 2022: $2,618 · 2023: $1,432 · 2024: $1,258 · 2025: $2,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,781 · Travel and Lodging: $1,291 · Grant: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,780.84 |
| Travel and Lodging | $1,291.14 |
| Grant | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,476.25 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Edwards Lifesciences Corporation | $1,855.42 | 2019-2025 | Evoque, Pascal |
| Boston Scientific Corporation | $1,345.39 | 2019-2025 | Watchman Flx, Watchman Access System, Eluvia |
| Novartis Pharmaceuticals Corporation | $969.12 | 2019-2025 | |
| Amgen INC. | $654.36 | 2020-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $653.07 | 2021-2025 | Brilinta |
| Janssen Pharmaceuticals, INC | $571.69 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $504.30 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $368.30 | 2020-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.80 | 2021-2025 | Jardiance |
| Medtronic, INC. | $277.51 | 2021-2025 | Micra, Corevalve Evolut R |
| Actelion Pharmaceuticals US, INC. | $257.59 | 2023-2025 | Opsumit, Uptravi |
| Pfizer INC. | $237.94 | 2022-2025 | |
| Shockwave Medical, INC | $237.93 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $230.41 | 2022-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $202.58 | 2022-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $125.93 | 2019-2023 | |
| Scpharmaceuticals INC. | $117.38 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $114.11 | 2024 | Arcalyst |
| Atricure, INC. | $91.56 | 2023 | |
| Philips North America LLC | $74.44 | 2023 | |
| Alnylam Pharmaceuticals INC. | $59.98 | 2025 | Onpattro |
| Melinta Therapeutics, LLC | $48.67 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $27.65 | 2019 | |
| Cardiva Medical, INC. | $24.37 | 2022 | |
| Lundbeck LLC | $23.02 | 2019 | |
| Bridgebio Pharma, INC. | $22.19 | 2025 | Attruby |
| Novo Nordisk INC | $21.57 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $21.43 | 2024 | |
| Impulse Dynamics (USA) INC. | $20.25 | 2025 | Optimizer |
| Siemens Medical Solutions USA, INC. | $19.06 | 2023 | Corpath Imaging System |
| Inari Medical, INC. | $17.61 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Livanova USA, INC. | $14.89 | 2022 | |
| Sensible Medical Innovations INC | $12.11 | 2024 | Reds System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.